Bluejay Diagnostics, Inc. Common Stock (BJDX) is a publicly traded Healthcare sector company. As of October 30, 2026, BJDX trades at $0.54 with a market cap of $2.54M and a P/E ratio of -0.06. BJDX moved -11.53% today. Year to date, BJDX is -79.63%; over the trailing twelve months it is -94.10%. Its 52-week range spans $0.52 to $40.80. Rallies surfaces BJDX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for BJDX, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $0.54 |
| Market Cap | $2.54M |
| P/E Ratio | -0.06 |
| EPS | $-15.25 |
| Dividend Yield | 0.00% |
| 52-Week High | $40.80 |
| 52-Week Low | $0.52 |
| Volume | 159.55K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-6.85M |
| Gross Margin | 0.00% |
BJDX analyst coverage data. Average price target: $0.00.